October 21, 2021 -- Waters and the University of Delaware have initiated a five-year collaboration focused on improving quality, yields, and efficiency in the manufacturing processes for biologics and new modalities.
As part of the collaboration, Waters' staff and university researchers will co-locate at the Immerse Delaware Lab, a state-of-the-art lab located on the university's campus. The Immerse Delaware Lab will feature a purpose-built research test bed with a focus on leveraging Waters' liquid chromatography-mass spectrometry system, which was designed to simplify the multiattribute monitoring of biotherapeutics, Waters said.
Initial projects will seek to explore novel methods of quantifying and ultimately minimizing process-related impurities from uncontrolled glycosylation, which negatively impacts drug efficacy. The projects will be paired with informatic solutions to predict the evolution of biotherapeutic products, the company said.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
